These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. Silver RM; Sutherland SE; Carreira P; Heyes MP J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618 [TBL] [Abstract][Full Text] [Related]
31. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes]. Ozawa S Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514 [TBL] [Abstract][Full Text] [Related]
32. Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. Ward SA; Walle T; Walle UK; Wilkinson GR; Branch RA Clin Pharmacol Ther; 1989 Jan; 45(1):72-9. PubMed ID: 2910639 [TBL] [Abstract][Full Text] [Related]
33. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects. Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063 [TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. de Morais SM; Goldstein JA; Xie HG; Huang SL; Lu YQ; Xia H; Xiao ZS; Ile N; Zhou HH Clin Pharmacol Ther; 1995 Oct; 58(4):404-11. PubMed ID: 7586932 [TBL] [Abstract][Full Text] [Related]
35. Genetic aspects of drug disposition and therapeutics. Guttendorf RJ; Wedlund PJ J Clin Pharmacol; 1992 Feb; 32(2):107-17. PubMed ID: 1613119 [No Abstract] [Full Text] [Related]
36. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. Xiao ZS; Goldstein JA; Xie HG; Blaisdell J; Wang W; Jiang CH; Yan FX; He N; Huang SL; Xu ZH; Zhou HH J Pharmacol Exp Ther; 1997 Apr; 281(1):604-9. PubMed ID: 9103550 [TBL] [Abstract][Full Text] [Related]
38. P-31 magnetic resonance spectroscopy of skeletal muscle in the eosinophilia-myalgia syndrome: a preliminary study. Clauw DJ; Hewes B; Nelson M; Katz P; Rajan S J Rheumatol; 1994 Apr; 21(4):654-7. PubMed ID: 8035389 [TBL] [Abstract][Full Text] [Related]
39. Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study. Madsen H; Nielsen KK; Brøsen K Br J Clin Pharmacol; 1995 Apr; 39(4):433-9. PubMed ID: 7640151 [TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism of S-mephenytoin 4'-hydroxylation. Daniel HI; Edeki TI Psychopharmacol Bull; 1996; 32(2):219-30. PubMed ID: 8783891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]